Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANGING: Intensive Insulin Glulisine in T2DM
NCT01203111Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2010
- Primary completion
- Jul 2012
- Modality
- Peptides
- Countries
- 10
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2010; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01203111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203111.